PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAsparaginase erwinia chrysanthemi
Asparaginase erwinia chrysanthemi
Download report
Favorite
Drugs Approved for Childhood Cancers
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
299 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C954096691425223
Precursor cell lymphoblastic leukemia-lymphomaD054198——3794641632223
Lymphoid leukemiaD007945—C913686551422195
LymphomaD008223—C85.91044204781
T-cell lymphomaD016399——51523427
T-cell lymphoma peripheralD016411——41323424
Philadelphia chromosomeD010677——4432—11
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.952112—138
Myeloid leukemia acuteD015470—C92.0479——20
Myeloid leukemiaD007951—C92368——17
Precursor t-cell lymphoblastic leukemia-lymphomaD054218——595——16
RecurrenceD012008——692—115
Extranodal nk-t-cell lymphomaD054391—C86.0291—313
SyndromeD013577——216——9
Myelodysplastic syndromesD009190—D46216——9
Acute diseaseD000208——332——8
PreleukemiaD011289——2—6——8
Show 30 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Biphenotypic leukemia acuteD015456—C95.024———5
NeoplasmsD009369—C8014———5
Hematologic neoplasmsD019337——22———4
HypersensitivityD006967HP_0012393T78.4011——24
PancreatitisD010195HP_0001733K8511——12
T-cell leukemiaD015458——12———2
Precursor b-cell lymphoblastic leukemia-lymphomaD015452——12———2
Healthy volunteers/patients————1——12
Urologic neoplasmsD014571—C64-C68—1———1
Urinary bladder neoplasmsD001749—C67—1———1
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—1————1
Prolymphocytic leukemia t-cellD015461—C91.61————1
Prolymphocytic leukemiaD015463——1————1
Blast crisisD001752——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920HP_0000819E08-E13————22
AtaxiaD001259—R27.0————11
Ataxia telangiectasiaD001260Orphanet_100G11.3————11
TelangiectasisD013684——————11
Cerebellar ataxiaD002524HP_0001251—————11
T-cell lymphoma cutaneousD016410——————11
HyperlipidemiasD006949HP_0003077E78.5————11
HyperlipoproteinemiasD006951HP_0010980—————11
ThromboembolismD013923HP_0001907—————11
Residual neoplasmD018365——————11
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 664 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,416 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use